In patients with atrial fibrillation who had a drug-eluting stent implanted at least 1 year prior, oral anticoagulation alone was noninferior to oral anticoagulation plus clopidogrel, researchers ...

A slew of National Institutes of Health grant terminations in the spring left affected Northwestern researchers with few ...

DES, adding clopidogrel in the chronic phase of coronary disease had no ischemic benefit and increased bleeding.

Novo Nordisk said on Thursday its experimental obesity drug CagriSema significantly reduced blood pressure in a late-stage ...

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections without regaining lost pounds.